DR. REDDY'S LABORATORIES LTD.

NSE : DRREDDYBSE : 500124ISIN CODE : INE089A01023Industry : Pharmaceuticals & DrugsHouse : Dr. Reddy's
BSE6004.7553.55 (+0.9 %)
PREV CLOSE ( ) 5951.20
OPEN PRICE ( ) 5988.25
BID PRICE (QTY) 6008.15 (5)
OFFER PRICE (QTY) 6009.00 (4)
VOLUME 2702
TODAY'S LOW / HIGH ( )5930.00 6008.00
52 WK LOW / HIGH ( )4383.4 6505.5
NSE5989.4038.6 (+0.65 %)
PREV CLOSE( ) 5950.80
OPEN PRICE ( ) 5975.05
BID PRICE (QTY) 5986.65 (4)
OFFER PRICE (QTY) 5989.35 (1)
VOLUME 96502
TODAY'S LOW / HIGH( ) 5928.00 5995.95
52 WK LOW / HIGH ( )4384.05 6505.9
Peer Companies Price () Chg () Chg (%) EPS () TTM P/E Volume (000's) 1 Year Return (%)

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.